<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>GuosenHealthcare | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-06T17:30:29+08:00</updated>
  <subtitle>国信医药最新研究成果、行业深度资讯展示与交流平台，引领健康投资、健康生活新风尚！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【国信医药】美年健康：大跌事出有因，探寻阿里战略 （重大事件快评）</title>
    <updated>2020-11-06T09:55:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/Q5yLSxsmj_zmcD_RyQXvrQ</id>
    <link href="https://mp.weixin.qq.com/s/Q5yLSxsmj_zmcD_RyQXvrQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】冠脉支架集采结果公布，中标价大幅下降 （行业重大事件快评）</title>
    <updated>2020-11-06T09:55:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/k63cOBPQyMaVlFJ2awQMWA</id>
    <link href="https://mp.weixin.qq.com/s/k63cOBPQyMaVlFJ2awQMWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】华润三九：销售费率下降，Q3利润翻番（三季报点评）</title>
    <updated>2020-11-05T09:56:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/b_a1PsBcmlOalj0a0RNWmA</id>
    <link href="https://mp.weixin.qq.com/s/b_a1PsBcmlOalj0a0RNWmA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】政策迭出、靴子落地，布局龙头“黄金坑”（2020年11月投资策略）</title>
    <updated>2020-11-04T16:07:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/tnD8qmyAXqYOLn738_xiDQ</id>
    <link href="https://mp.weixin.qq.com/s/tnD8qmyAXqYOLn738_xiDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】欧洲疫情二次爆发，关注三季报业绩边际变化（周观点）</title>
    <updated>2020-11-02T10:53:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/kqTqM1vzy6r4UhXOiILmkg</id>
    <link href="https://mp.weixin.qq.com/s/kqTqM1vzy6r4UhXOiILmkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】华兰生物：疫苗高速增长，血制品表现平淡（三季报点评）</title>
    <updated>2020-11-02T10:53:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/rrKj1GmvTtrpcE5t9pn3oA</id>
    <link href="https://mp.weixin.qq.com/s/rrKj1GmvTtrpcE5t9pn3oA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】贝瑞基因：肿瘤早筛优质赛道，数据持续优化（三季报点评）</title>
    <updated>2020-11-02T10:53:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/XzdluBIxLual2oAeNFBtIg</id>
    <link href="https://mp.weixin.qq.com/s/XzdluBIxLual2oAeNFBtIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】上海医药：研发加码持续，创新开花可期（三季报点评）</title>
    <updated>2020-11-02T10:53:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/P_UgFFfOHe9dTL9NMc8Sww</id>
    <link href="https://mp.weixin.qq.com/s/P_UgFFfOHe9dTL9NMc8Sww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】药明康德：Q3增长提速，龙头强者恒强（三季报点评）</title>
    <updated>2020-10-30T14:44:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/dLox-LUFQW5gJLWKI0Eb9w</id>
    <link href="https://mp.weixin.qq.com/s/dLox-LUFQW5gJLWKI0Eb9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】迈瑞医疗：器械龙头加速全球化，抗疫产品延续高增长（三季报点评）</title>
    <updated>2020-10-30T14:44:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/Az5olI-RYr7Chs6KrGxFLw</id>
    <link href="https://mp.weixin.qq.com/s/Az5olI-RYr7Chs6KrGxFLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】乐普医疗：扣非业绩稳健增长，期待创新器械放量（三季报点评）</title>
    <updated>2020-10-30T14:44:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/6HYdeBv-5qyDOLG1eexU_A</id>
    <link href="https://mp.weixin.qq.com/s/6HYdeBv-5qyDOLG1eexU_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】泰格医药：业绩符合预期，Q4有望持续恢复（三季报点评）</title>
    <updated>2020-10-30T14:44:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/9AD3787yvMIRzmQceNNgpQ</id>
    <link href="https://mp.weixin.qq.com/s/9AD3787yvMIRzmQceNNgpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】通化东宝：单季增速略超预期，甘精持续放量（三季报点评）</title>
    <updated>2020-10-30T14:44:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/2DulLBRLYkfMV6cXFycr1Q</id>
    <link href="https://mp.weixin.qq.com/s/2DulLBRLYkfMV6cXFycr1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】白云山：Q3 强势回暖，子公司分拆上市推进（三季报点评）</title>
    <updated>2020-10-30T14:44:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/WaGls0_YXxDhRrUmXl8xRQ</id>
    <link href="https://mp.weixin.qq.com/s/WaGls0_YXxDhRrUmXl8xRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】天坛生物：Q3增速回升，定增募投新产能（三季报点评）</title>
    <updated>2020-10-29T10:00:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/GJ4NZ6-cWu2F7kw1rgd3MQ</id>
    <link href="https://mp.weixin.qq.com/s/GJ4NZ6-cWu2F7kw1rgd3MQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】华大基因：新冠检测持续，海外扩张加速（三季报点评）</title>
    <updated>2020-10-29T10:00:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/t2tdOQoyyD5fDGDhN-C8rw</id>
    <link href="https://mp.weixin.qq.com/s/t2tdOQoyyD5fDGDhN-C8rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】凯利泰：单季恢复正增长，中长期持续看好（三季报点评）</title>
    <updated>2020-10-29T10:00:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/2nKLxzH7ZK8G39lzipctLw</id>
    <link href="https://mp.weixin.qq.com/s/2nKLxzH7ZK8G39lzipctLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】迪安诊断：业绩超预期，实验室扭亏加速（三季报点评）</title>
    <updated>2020-10-28T12:24:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/t0WXSrVpmmkoHBtBMSvUBA</id>
    <link href="https://mp.weixin.qq.com/s/t0WXSrVpmmkoHBtBMSvUBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】爱尔眼科：业绩超预期，眼科真龙头（三季报点评）</title>
    <updated>2020-10-28T12:24:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/eh5yoV_hcnhKLhQs26KOLQ</id>
    <link href="https://mp.weixin.qq.com/s/eh5yoV_hcnhKLhQs26KOLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【国信医药】贝达药业：埃克替尼稳健增长，业绩符合预期 （三季报点评）</title>
    <updated>2020-10-28T12:24:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/_SRRIipjYSU66ixHD1PksA</id>
    <link href="https://mp.weixin.qq.com/s/_SRRIipjYSU66ixHD1PksA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>